Quimi Daphne 4

What Happened

• Daphne Quimi, a director of Century Therapeutics (IPSC), received a derivative equity award on 2026-06-11 covering 74,000 shares. The award was reported with a $0.00 per-share acquisition price (transaction code A), indicating an option/award rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-06-11; Form 4 filed: 2026-06-12 (timely filing).
• Security: derivative award (option) for 74,000 shares; reported acquisition price: $0.00.
• Vesting: the option vests on the earlier of (a) June 11, 2027 or (b) the next annual meeting of stockholders, subject to continued service (per footnote).
• Shares owned after transaction: not specified in the filing.
• Filing accession: 0001543031-26-000002. Transaction code: A (award/grant).

Context

• This was a compensation award (an option-like derivative) rather than a purchase of existing shares; it does not represent an immediate cash outlay or sale. Such grants are commonly part of director compensation and vest over time subject to service. The filing was made the next day and is not marked late.